Dream Pharma to introduce sustained release form of phentermine HCl

Published: 2007-11-06 06:58:00
Updated: 2007-11-06 06:58:00
Dream Pharma plans to sell the slow release form of phentermine hydrochloride 30 mg within this month, sparking more heated competition among anti-obesity drug makers.

Developed by the Netherlands-based Eurodrug Laboratories, phentermine (Panbesy capsule) is indicated in the management of exo...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.